Skip to product information
1 of 1

Medical Education Hub

Meetings Events & Conference Coordinators Updates in Cancer Therapies A Review of the 2023 ASCO & ESMO Annual Meetings

Meetings Events & Conference Coordinators Updates in Cancer Therapies A Review of the 2023 ASCO & ESMO Annual Meetings

Regular price €20,00 EUR
Regular price Sale price €20,00 EUR
Sale Sold out
Taxes included. Shipping calculated at checkout.
Quantity

Meetings Events & Conference Coordinators Updates in Cancer Therapies A Review of the 2023 ASCO & ESMO Annual Meetings

Include: 17 videos, size: 3.24 GB

The Updates in Cancer Therapies: A Review of the 2023 ASCO & ESMO Annual Meetings organized by Meetings Events & Conference Coordinators (MECC) is designed to provide a comprehensive overview of the latest advancements in cancer therapies presented at these two major oncology conferences.

Target Audience:

  • Medical oncologists
  • Radiation oncologists
  • Surgical oncologists
  • Oncology nurses
  • Advanced registered nurse practitioners
  • Oncology pharmacists
  • Physician assistants
  • Researchers and clinical scientists involved in cancer care

This event focuses on the most significant and practice-changing data from the ASCO and ESMO annual meetings, covering a wide range of cancer types and treatment modalities. It includes presentations, Q&A sessions, and discussions led by key opinion leaders in each cancer field

 

 Topics:

  • 2023 ASCO ESMO Updates in Prostate Cancer Combination Therapy becoming the best approach.mp4
    Antibody Drug Conjugates in NSCLC.mp4
    ASCO and ESMO Updates 2023 Metastatic Breast Cancer.mp4
    ASCO ESMO updates.mp4
    Current and Emerging Treatments for Patients With HR+ HER2- Early Breast Cancer.mp4
    Incidental Gallbladder Cancer Making the case for neoadjuvant therapy.mp4
    Modern Challenges and New Options in Lymphoma Treatment.mp4
    Most Relevant Data on lmmunotherapy in Neo-Adjuvant, Adjuvant, and Metastatic NSCLC.mp4
    Myeloma A 2024 Perspective Based on what has happened in 2023.mp4
    New Developments in CLL.mp4
    New Developments in EGFR and K-RAS Therapies in NSCLC.mp4
    Novel Frontiers in the Use of cDNA in Oncology.mp4
    Updates in Colorectal Cancer.mp4
    Updates in Gynecologic Malignancies.mp4
    Updates in Kidney and Bladder Cancers Where are we with immunotherapy and precision medicine.mp4
    Updates on T-cell lymphomas.mp4
    Updates on Targeting ALK, R051, and RET in NSCLC.mp4
View full details